Wednesday, August 15, 2018 5:12:18 PM
The price isn’t fixed. Now the question is, what good would that deal be if GERS would have sold the patents seperately.
The selling of the patents seperatly is pure speculation. The price of the deal being based on possible higher future earnings isn’t.
I suppose you ask me to share a link because you like ihub to be as complete as possible, because I don’t think you didn’t know this part of the deal. You’re to smart for that, not to have figured that out yet.
I’ve shared that text before. It’s easy to find. So if you really need it. It should take only a minute. But I wouldn’t know why you need it to answer the question.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM